CI:NYE-Cigna Corp (USD)

COMMON STOCK | Healthcare Plans |

Last Closing

USD 336

Change

0.00 (0.00)%

Market Cap

N/A

Volume

2.71M

Analyst Target

USD 242.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-20 )

Largest Industry Peers for Healthcare Plans

Symbol Name Price(Change) Market Cap
UNH UnitedHealth Group Incorporate..

N/A

USD 525.99B
ELV Elevance Health Inc

N/A

USD 118.03B
CNC Centene Corp

N/A

USD 32.62B
MOH Molina Healthcare Inc

N/A

USD 16.98B
OSCR Oscar Health Inc

N/A

USD 4.35B
NEUE NeueHealth Inc

N/A

USD 0.05B
CVS CVS Health Corp

N/A

N/A
HUM Humana Inc

N/A

N/A

ETFs Containing CI

AILV 4.45 % 0.00 %

N/A

N/A
CBUF:XETRA iShares MSCI World Health.. 3.38 % 0.00 %

N/A

USD 1.13B
CBUF:F iShares V Public Limited .. 3.27 % 0.00 %

N/A

N/A
WHCS:SW iShares MSCI World Health.. 3.22 % 0.00 %

N/A

N/A
SHRY First Trust Bloomberg Sha.. 3.14 % 0.00 %

N/A

USD 0.02B
FSST Fidelity Sustainability U.. 2.63 % 0.00 %

N/A

USD 0.02B
ZPRU:XETRA SPDR® MSCI USA Value UCI.. 2.33 % 0.00 %

N/A

USD 0.13B
UVAL:SW SPDR® MSCI USA Value UCI.. 2.33 % 0.00 %

N/A

USD 0.14B
DSTL Distillate US Fundamental.. 1.59 % 0.00 %

N/A

USD 2.11B
IQSA:F Invesco Markets II PLC - .. 1.53 % 0.00 %

N/A

N/A
IQSE:F Invesco Markets II PLC - .. 1.53 % 0.00 %

N/A

N/A
IQSA:XETRA Invesco Quantitative Stra.. 1.46 % 0.00 %

N/A

USD 0.07B
IQSE:XETRA Invesco Quantitative Stra.. 1.46 % 0.00 %

N/A

USD 0.05B
DMFC:SW iShares Edge MSCI World M.. 1.42 % 0.00 %

N/A

N/A
IBCZ:XETRA iShares Edge MSCI World M.. 1.40 % 0.00 %

N/A

USD 0.40B
IS07:XETRA iShares Edge MSCI World M.. 1.39 % 0.00 %

N/A

USD 0.01B
IFSW:SW iShares Edge MSCI World M.. 1.39 % 0.00 %

N/A

USD 0.60B
ESGL ESGL Holdings Limited Ord.. 0.00 % 0.40 %

N/A

USD 0.08B
FUM:CA 0.00 % 0.80 %

N/A

N/A
IHF iShares U.S. Healthcare P.. 0.00 % 0.43 %

N/A

N/A
QSY 0.00 % 0.38 %

N/A

N/A
DUSA 0.00 % 0.63 %

N/A

N/A
HONR 0.00 % 0.65 %

N/A

N/A
BUYB:LSE Invesco Global Buyback Ac.. 0.00 % 0.00 %

N/A

N/A
RYH 0.00 % 0.40 %

N/A

N/A
VVL:CA Vanguard Global Value Fac.. 0.00 % 0.40 %

N/A

N/A
XXM:CA 0.00 % 0.68 %

N/A

N/A
UVAL:LSE SPDR® MSCI USA Value UCI.. 0.00 % 0.00 %

N/A

USD 0.14B
XMWD:LSE Xtrackers MSCI World Swap.. 0.00 % 0.00 %

N/A

N/A
USVL:LSE SPDR® MSCI USA Value UCI.. 0.00 % 0.00 %

N/A

USD 0.14B
TPHC:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 9.67M
TPXE:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.27B
TPXH:PA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.22B
IBCZ:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
IS07:F iShares IV Public Limited.. 0.00 % 0.00 %

N/A

N/A
ZPRU:F SSgA SPDR ETFs Europe II .. 0.00 % 0.00 %

N/A

USD 0.13B
TTPX:XETRA Amundi Index Solutions - .. 0.00 % 0.00 %

N/A

USD 0.40B
VGVL:XETRA 0.00 % 0.00 %

N/A

N/A
VMUS:XETRA 0.00 % 0.00 %

N/A

N/A
HDIV 0.00 % 0.00 %

N/A

N/A
FDWM Fidelity Covington Trust .. 0.00 % 0.00 %

N/A

USD 4.09M
NTZG 0.00 % 0.00 %

N/A

N/A
BUYB:SW Invesco Global Buyback Ac.. 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Healthcare Plans) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -62.60% 38% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -62.60% 38% F 10% F
Trailing 12 Months  
Capital Gain -63.49% 38% F 5% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -63.49% 38% F 9% A-
Trailing 5 Years  
Capital Gain -34.26% 67% D+ 20% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -34.26% 67% D+ 25% F
Average Annual (5 Year Horizon)  
Capital Gain 14.97% 63% D 77% C+
Dividend Return 16.45% 63% D 76% C+
Total Return 1.47% 60% D- 34% F
Risk Return Profile  
Volatility (Standard Deviation) 20.46% 75% C 51% F
Risk Adjusted Return 80.38% 88% B+ 90% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:

There is nothing we particularly dislike